Repligen マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Olivier Loeillot
最高経営責任者
US$5.4m
報酬総額
| CEO給与比率 | 2.5% |
| CEO在任期間 | 1.1yrs |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 1.8yrs |
| 取締役会の平均在任期間 | 8.7yrs |
経営陣の近況
Recent updates
Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$24m |
| Dec 31 2023 | US$5m | US$138k | US$36m |
報酬と市場: Olivierの 総報酬 ($USD 5.45M ) は、 US市場 ($USD 7.94M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Olivierの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Olivier Loeillot (54 yo)
1.1yrs
在職期間
US$5,445,065
報酬
Mr. Olivier Loeillot is President of Repligen Corporation from October 02, 2023 & served as it's Chief Commercial Officer and serves as it's CEO & Director since September 1, 2024. Mr. Loeillot served a co...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chair | 9.5yrs | US$7.93m | 0.18% $ 14.2m | |
| President | 1.1yrs | US$5.45m | データなし | |
| CFO & Chief Compliance Officer | 1.2yrs | US$2.03m | データなし | |
| Chief Operating Officer | 4.7yrs | US$3.74m | 0.0075% $ 585.2k | |
| Senior Vice President of Research & Development | 8.1yrs | US$1.66m | 0.010% $ 798.4k | |
| Chief Information Officer | no data | データなし | データなし | |
| Global Head of Investor Relations | no data | データなし | データなし | |
| Global Head of Legal | no data | データなし | データなし | |
| VP & Global Head of Sales | 2.1yrs | データなし | データなし | |
| Senior Director of Marketing | less than a year | データなし | データなし | |
| Vice President of Human Resources | 1.8yrs | データなし | データなし | |
| Senior VP of Strategy and Business Development & Global Head of Bioprocess Analytics | 4.8yrs | データなし | データなし |
1.8yrs
平均在職期間
60yo
平均年齢
経験豊富な経営陣: RGENの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chair | 9.5yrs | US$7.93m | 0.18% $ 14.2m | |
| President | less than a year | US$5.45m | データなし | |
| Independent Director | 9.1yrs | US$322.84k | 0.022% $ 1.7m | |
| Member of Scientific Advisory Board | 8.7yrs | データなし | データなし | |
| Independent Director | 1.8yrs | US$453.50k | 0.0070% $ 544.7k | |
| Lead Independent Director | 19.2yrs | US$431.12k | 0.16% $ 12.6m | |
| Member of Scientific Advisory Board | 8.7yrs | データなし | データなし | |
| Member of Scientific Advisory Board & Independent Director | 8.7yrs | US$282.84k | 0.00095% $ 73.9k | |
| Member of Scientific Advisory Board | 8.7yrs | データなし | データなし | |
| Independent Director | 4.7yrs | US$287.84k | 0.0042% $ 326.1k | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Director | 10.4yrs | US$307.84k | 0.0071% $ 551.0k |
8.7yrs
平均在職期間
64yo
平均年齢
経験豊富なボード: RGENの 取締役会 は 経験豊富 であると考えられます ( 8.7年の平均在任期間)。